Veracyte, Inc.
METHODS FOR EVALUATING LUNG CANCER STATUS
Last updated:
Abstract:
The disclosure in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative-genes. In other aspects, the disclosure provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the disclosure.
Status:
Application
Type:
Utility
Filling date:
15 May 2020
Issue date:
11 Feb 2021